Skip to content

Clinical research on the pathogenesis of asthenospermia (and) or oligospermia through gut microbiome

Clinical research on the pathogenesis of asthenospermia (and) or oligospermia through gut microbiome

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043662
Enrollment
Unknown
Registered
2021-02-25
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthenospermia (and) or oligospermia

Interventions

asthenospermia (and) or oligospermia:none
Normal group:none

Sponsors

Department of Gastroenterology, Second Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for the trial group: 1. Males aged 18-65 years old. 2. No long-term exposure to radioactive rays and toxic substances. 3. No drug use in the past 2 months. 4. No history of STDs. 5. No antibiotics for two months. 6. No history of systemic corticosteroid use. 7. Improve semen routine, hormone six items, blood routine examination, and routine semen malformation rate = 40%. 8. Willing to participate in this study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Fever in the past 2 months. 2. Urinary tract infection or inflammation in the past 2 months. 3. Use immunosuppressants, systemic corticosteroids or cancer chemotherapy in the past 2 months. 4. There is a history of varicocele. 5. It cannot cooperate with the research for any reason or the researcher thinks it is not suitable to be included in this trial.

Design outcomes

Primary

MeasureTime frame
gut microbiota;

Countries

China

Contacts

Public ContactShimng Yang

The Second Affiliated Hospital of Army Medical University

13228686589@163.com+86 13228686589

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026